Powell Saul R, Davies Kelvin J A, Divald Andras
The Feinstein Institute for Medical Research, Long Island Jewish Medical Center Campus, New Hyde Park, NY 11042, USA.
J Mol Cell Cardiol. 2007 Jan;42(1):265-9. doi: 10.1016/j.yjmcc.2006.10.010. Epub 2006 Nov 30.
The ubiquitin-proteasome system has been implicated in both cardiac physiology and pathophysiology. Research in this area has been hampered by the lack of a simple, reproducible method to assess 26S-proteasome peptidase activities. The current report demonstrates that one reason for lack of reproducibility is the myriad of ATP concentrations, many of them excessive, which have been used to stimulate peptidase activity. The chymotrypsin-like or caspase-like activities of 26S-proteasome in cardiac tissue isolates were determined using Suc-LLVY-AMC or Z-LLE-AMC, respectively, over a range of ATP concentrations up to 2 mmol/L. The optimal ATP concentration to assess both peptidase activities was found to be in the low micromolar range (from 6 to 100 micromol/L) depending on the cardiac tissue isolate protein (10 to 90 microg protein) contained in the reaction. Increasing ATP beyond the optimal range was inhibitory. In general, chymotrypsin-like and caspase-like activities could be stimulated 2- to 2.5-fold and 1.4- to 1.8-fold, respectively, over basal (ATP, 0 micromol/L), and could be effectively inhibited with lactacystin or Z-Pro-Nle-Asp-CHO, respectively. Based on these observations, an optimized method is presented for ex vivo determination of cardiac 26S-proteasome peptidase activities which was used to confirm inactivation of this complex by myocardial ischemia and reperfusion.
泛素-蛋白酶体系统与心脏生理和病理生理均有关联。该领域的研究因缺乏一种简单、可重复的方法来评估26S蛋白酶体的肽酶活性而受到阻碍。本报告表明,缺乏可重复性的一个原因是用于刺激肽酶活性的ATP浓度众多,其中许多浓度过高。使用Suc-LLVY-AMC或Z-LLE-AMC分别在高达2 mmol/L的一系列ATP浓度下测定心脏组织分离物中26S蛋白酶体的类胰凝乳蛋白酶样或类半胱天冬酶样活性。发现评估这两种肽酶活性的最佳ATP浓度处于低微摩尔范围(6至100微摩尔/升),这取决于反应中所含心脏组织分离物蛋白(10至9微克蛋白)。将ATP浓度增加到超出最佳范围具有抑制作用。一般而言,类胰凝乳蛋白酶样和类半胱天冬酶样活性分别可比基础水平(ATP,0微摩尔/升)刺激2至2.5倍和1.4至1.8倍,并且可分别被乳胞素或Z-Pro-Nle-Asp-CHO有效抑制。基于这些观察结果,提出了一种用于离体测定心脏26S蛋白酶体肽酶活性的优化方法,该方法用于证实心肌缺血和再灌注对该复合物的失活作用。